{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:24:35Z","timestamp":1790807075290,"version":"4.1.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,3,5]],"date-time":"2014-03-05T00:00:00Z","timestamp":1393977600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Diabetol"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1007\/s00592-014-0557-3","type":"journal-article","created":{"date-parts":[[2014,3,4]],"date-time":"2014-03-04T06:55:40Z","timestamp":1393916140000},"page":"339-351","source":"Crossref","is-referenced-by-count":43,"title":["Systematic review: continuous intraperitoneal insulin infusion with implantable insulin pumps for diabetes mellitus"],"prefix":"10.1007","volume":"51","author":[{"given":"Nienke","family":"Spaan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Teplova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerrit","family":"Stam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos","family":"Spaan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cees","family":"Lucas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,3,5]]},"reference":[{"issue":"3","key":"557_CR1","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.ecl.2010.05.011","volume":"39","author":"DM Maahs","year":"2010","unstructured":"Maahs DM, West NA, Lawrence JM, Mayer-Davis EJ (2010) Epidemiology of type 1 diabetes. Endocrinol Metab Clin North Am 39(3):481\u2013497","journal-title":"Endocrinol Metab Clin North Am"},{"key":"557_CR2","unstructured":"World Health Organisation (2013) Diabetes fact sheet no 312"},{"issue":"Supplement 1","key":"557_CR3","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.2337\/dc13-S067","volume":"36","author":"American Diabetes Association","year":"2013","unstructured":"American Diabetes Association (2013) Diagnosis and classification of diabetes mellitus. Diabetes Care 36(Supplement 1):S67\u2013S74. doi: 10.2337\/dc13-S067","journal-title":"Diabetes Care"},{"key":"557_CR4","first-page":"A580","volume":"153","author":"CA Baan","year":"2009","unstructured":"Baan CA, van Baal PHM, Jacobs-van der Bruggen MAM, Verkley H, Poos MJJC, Hoogenveen RT, Schoemaker CG (2009) Diabetes mellitus in Nederland: schatting van de huidige ziektelast en prognose voor 2025 (DM in the Netherlands: estimation of the current burden of disease, prognoses for 2025). Neth J Med 153:A580","journal-title":"Neth J Med"},{"key":"557_CR5","unstructured":"International Diabetes Federation (2011) In: IDF (ed) Diabetes atlas, 5th edn"},{"issue":"7","key":"557_CR6","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1093\/clinchem\/47.7.1157","volume":"47","author":"U Krishnamurti","year":"2001","unstructured":"Krishnamurti U, Steffes MW (2001) Glycohemoglobin: a primary predictor of the development or reversal of complications of diabetes mellitus. Clin Chem 47(7):1157\u20131165","journal-title":"Clin Chem"},{"issue":"Supplement 1","key":"557_CR7","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.2337\/dc13-S011","volume":"36","author":"American Diabetes Association","year":"2013","unstructured":"American Diabetes Association (2013) Standards of medical care in diabetes\u20142013. Diabetes Care 36(Supplement 1):S11\u2013S66. doi: 10.2337\/dc13-S011","journal-title":"Diabetes Care"},{"issue":"8","key":"557_CR8","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.2337\/dc08-2340","volume":"32","author":"SJ Logtenberg","year":"2009","unstructured":"Logtenberg SJ, Kleefstra N, Houweling ST, Groenier KH, Gans RO, van Ballegooie E, Bilo HJ (2009) Improved glycemic control with intraperitoneal versus subcutaneous insulin in type 1 diabetes. Diabetes Care 32(8):1372\u20131377. doi: 10.2337\/dc08-2340","journal-title":"Diabetes Care"},{"issue":"7","key":"557_CR9","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.2337\/dc06-0582","volume":"29","author":"S Baillot-Rudoni","year":"2006","unstructured":"Baillot-Rudoni S, Apostol D, Vaillant G, Brun JM, Renard E, On behalf of the EVADIAC study group (2006) Implantable pump therapy restores metabolic control and quality of life in type 1 diabetic patients with Buschke\u2019s nonsystemic scleroderma [1]. Diabetes Care 29(7):1710. doi: 10.2337\/dc06-0582","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"557_CR10","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1089\/dia.2011.0058","volume":"13","author":"A Penfornis","year":"2011","unstructured":"Penfornis A, Personeni E, Borot S (2011) Evolution of devices in diabetes management. Diabetes Technol Ther 13(Suppl 1):S93\u2013S102. doi: 10.1089\/dia.2011.0058","journal-title":"Diabetes Technol Ther"},{"issue":"3","key":"557_CR11","first-page":"738","volume":"77","author":"A Giacca","year":"1993","unstructured":"Giacca A, Caumo A, Galimberti G, Petrella G, Librenti MC, Scavini M, Pozza G, Micossi P (1993) Peritoneal and subcutaneous absorption of insulin in type I diabetic subjects. J Clin Endocrinol Metab 77(3):738\u2013742","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"557_CR12","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.diabet.2006.10.004","volume":"33","author":"E Renard","year":"2007","unstructured":"Renard E, Schaepelynck-Belicar P, On behalf of the EVADIAC group (2007) Implantable insulin pumps: a position statement about their clinical use. Diabetes Metab 33(2):158\u2013166. doi: 10.1016\/j.diabet.2006.10.004","journal-title":"Diabetes Metab"},{"key":"557_CR13","unstructured":"College voor Zorgverzekeringen (2007) Implanteerbare insulinepomp geen te verzekeren prestatie Adviesaanvraag Znw\u2014uitspraak. CVZ. (Implantable insulin pump- not an insurable achievement. Advice judgement by the Board for health insurances)"},{"issue":"2","key":"557_CR14","first-page":"65","volume":"65","author":"SJ Logtenberg","year":"2007","unstructured":"Logtenberg SJ, van Ballegooie E, Israel-Bultman H, van Linde A, Bilo HJ (2007) Glycaemic control, health status and treatment satisfaction with continuous intraperitoneal insulin infusion. Neth J Med 65(2):65\u201370","journal-title":"Neth J Med"},{"issue":"3","key":"557_CR15","first-page":"135","volume":"3","author":"GV Gill","year":"1986","unstructured":"Gill GV, Husband DJ, Wright PD, Sharpe G, Taylor R, Walford S, Marshall SM, Alberti KG (1986) The management of severe brittle diabetes with \u201cInfusaid\u201d implantable pumps. Diabetes Res 3(3):135\u2013137","journal-title":"Diabetes Res"},{"issue":"1","key":"557_CR16","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1749-6632.1988.tb31813.x","volume":"531","author":"P Lord","year":"1988","unstructured":"Lord P, Allami H, Davis M, Diaz R, Heck P, Fischell R (1988) MiniMed technologies programmable implantable infusion system. Ann N Y Acad Sci 531(1):66\u201371","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"557_CR17","first-page":"39","volume":"1","author":"J Mirouze","year":"1983","unstructured":"Mirouze J, Selam JL, Slingeneyer A, Chaptal PA, Hedon B, Mares P, Franetzki M, Prestele K, Millet P, Beraud JJ (1983) Clinical experience in human diabetics with portable and implantable insulin minipumps. Life Support Syst 1(1):39\u201349","journal-title":"Life Support Syst"},{"key":"557_CR18","unstructured":"Scavini M, Schade DS (1996) Implantable Insulin Pumps. Clin Diabetes 14(2):30\u201336"},{"key":"557_CR19","unstructured":"Business Wire (2001) MiniMed Inc. Stockholders approve merger with medtronic, Inc."},{"key":"557_CR20","first-page":"39","volume-title":"Therapeutic strategies in diabetes","author":"E Renard","year":"2009","unstructured":"Renard E (2009) New developments in insulin administration. In: Stehouwer CDA, Schaper NC (eds) Therapeutic strategies in diabetes. Clinical Publishing, Oxford, pp 39\u201366"},{"issue":"10","key":"557_CR21","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jclinepi.2009.06.006","volume":"62","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, Mulrow C, G\u00f8tzsche PC, Ioannidis JPA, Clarke M, Devereaux PJ, Kleijnen J, Moher D (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 62(10):e1\u2013e34","journal-title":"J Clin Epidemiol"},{"key":"557_CR22","unstructured":"Higgins JPT, Green S (2011) (eds) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from http:\/\/www.cochrane-handbook.org"},{"key":"557_CR23","unstructured":"Systematic review: treatment of diabetes with intraperitoneal insulin infusion by way of an implantable insulin pump (2012) http:\/\/www.crd.york.ac.uk\/PROSPERO\/display_record.asp?ID=CRD42012002150"},{"key":"557_CR24","unstructured":"Higgins JPT, Altman DG, Sterne JAC (2011) (eds) Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (eds) Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from http:\/\/www.cochrane-handbook.org"},{"key":"557_CR25","unstructured":"Viswanathan M, Berkman ND (2011) Development of the RTI Item Bank on Risk of Bias and Precision of Observational Studies. Methods Research Report. (Prepared by the RTI International\u2013University of North Carolina Evidence-based Practice Center under Contract No. 290-2007-0056-I.) AHRQ Publication No. 11-EHC028-EF. Rockville, MD: Agency for Healthcare Research and Quality. Available at: http:\/\/www.effectivehealthcare.ahrq.gov\/reports\/final.cfm"},{"issue":"Supplement 1","key":"557_CR26","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.2337\/dc11-S011","volume":"34","author":"American Diabetes Association","year":"2011","unstructured":"American Diabetes Association (2011) Standards of medical care in diabetes\u20142011. Diabetes Care 34(Supplement 1):S11\u2013S61. doi: 10.2337\/dc11-S011","journal-title":"Diabetes Care"},{"key":"557_CR27","unstructured":"Brozek J, Oxman A, Sch\u00fcnemann H (2008) GRADEpro [Computer program]. Version 3.2 for windows"},{"issue":"16","key":"557_CR28","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1001\/jama.1996.03540160044031","volume":"276","author":"CD Saudek","year":"1996","unstructured":"Saudek CD, Duckworth WC, Giobbie-Hurder A, Henderson WG, Henry RR, Kelley DE, Edelman SV, Zieve FJ, Adler RA, Anderson JW, Anderson RJ, Hamilton BP, Donner TW, Kirkman MS, Morgan NA (1996) Implantable insulin pump versus multiple-dose insulin for non-insulin-dependent diabetes mellitus: a randomized clinical trial. J Am Med Assoc 276(16):1322\u20131327. doi: 10.1001\/jama.276.16.1322","journal-title":"J Am Med Assoc"},{"issue":"10","key":"557_CR29","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.2337\/diacare.21.10.1596","volume":"21","author":"WC Duckworth","year":"1998","unstructured":"Duckworth WC, Saudek CD, Giobbie-Hurder A, Henderson WG, Henry RR, Kelley DE, Edelman SV, Zieve FJ, Adler RA, Anderson JW, Anderson RJ, Hamilton BP, Donner TW, Kirkman MS, Morgan NA (1998) The veterans affairs implantable insulin pump study: effect on cardiovascular risk factors. Diabetes Care 21(10):1596\u20131602","journal-title":"Diabetes Care"},{"issue":"6","key":"557_CR30","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S0002-9610(98)00273-6","volume":"176","author":"JS Thompson","year":"1998","unstructured":"Thompson JS, Duckworth WC, Saudek CD, Giobbie-Hurder A (1998) Surgical experience with implantable insulin pumps. Am J Surg 176(6):622\u2013626. doi: 10.1016\/S0002-9610%2898%2900273-6","journal-title":"Am J Surg"},{"issue":"1","key":"557_CR31","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00423-008-0437-9","volume":"395","author":"JW Haveman","year":"2010","unstructured":"Haveman JW, Logtenberg SJ, Kleefstra N, Groenier KH, Bilo HJ, Blomme AM (2010) Surgical aspects and complications of continuous intraperitoneal insulin infusion with an implantable pump. Langenbecks Arch Surg 395(1):65\u201371. doi: 10.1007\/s00423-008-0437-9","journal-title":"Langenbecks Arch Surg"},{"issue":"3","key":"557_CR32","first-page":"191","volume":"3","author":"K Irsigler","year":"1990","unstructured":"Irsigler K, Hutter R, Kritz H, Abrahamian H, Lochli S, Hagmuller G, Veit F, Denck H (1990) Evaluation of long-term treatment with implanted insulin infusion devices (1981\u20131988). Diabetes Nutr Metab Clin Exp 3(3):191\u2013201","journal-title":"Diabetes Nutr Metab Clin Exp"},{"issue":"8","key":"557_CR33","doi-asserted-by":"crossref","first-page":"847","DOI":"10.2337\/diacare.17.8.847","volume":"17","author":"MJ Haardt","year":"1994","unstructured":"Haardt MJ, Selam JL, Slama G, Bethoux JP, Dorange C, Mace B, Ramaniche ML, Bruzzo F (1994) A cost-benefit comparison of intensive diabetes management with implantable pumps versus multiple subcutaneous injections in patients with type I diabetes. Diabetes Care 17(8):847\u2013857","journal-title":"Diabetes Care"},{"issue":"1","key":"557_CR34","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2337\/diacare.15.1.53","volume":"15","author":"JL Selam","year":"1992","unstructured":"Selam JL, Raccah D, Jean-Didier N, Lozano JL, Waxman K, Charles MA (1992) Randomized comparison of metabolic control achieved by intraperitoneal insulin infusion with implantable pumps versus intensive subcutaneous insulin therapy in type I diabetic patients. Diabetes Care 15(1):53\u201358","journal-title":"Diabetes Care"},{"issue":"6","key":"557_CR35","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1089\/dia.2010.0209","volume":"13","author":"P Schaepelynck","year":"2011","unstructured":"Schaepelynck P, Renard E, Jeandidier N, Hanaire H, Fermon C, Rudoni S, Catargi B, Riveline JP, Guerci B, Millot L, Martin JF, Sola A, on behalf of the EVADIAC Group (2011) A recent survey confirms the efficacy and the safety of implanted insulin pumps during long-term use in poorly controlled type 1 diabetes patients. Diabetes Technol Thera 13(6):657\u2013660. doi: 10.1089\/dia.2010.0209","journal-title":"Diabetes Technol Thera"},{"issue":"7","key":"557_CR36","doi-asserted-by":"crossref","first-page":"877","DOI":"10.2337\/diacare.15.7.877","volume":"15","author":"JL Selam","year":"1992","unstructured":"Selam JL, Micossi P, Dunn FL, Nathan DM (1992) Clinical trial of programmable implantable insulin pump for type I diabetes. Diabetes Care 15(7):877\u2013885","journal-title":"Diabetes Care"},{"issue":"3","key":"557_CR37","doi-asserted-by":"crossref","first-page":"388","DOI":"10.2337\/diacare.18.3.388","volume":"18","author":"H Hanaire-Broutin","year":"1995","unstructured":"Hanaire-Broutin H, Broussolle C, Jeandidier N, Renard E, Guerci B, Haardt MJ, Lassmann-Vague V (1995) Feasibility of intraperitoneal insulin therapy with programmable implantable pumps in IDDM: a multicenter study. Diabetes Care 18(3):388\u2013392","journal-title":"Diabetes Care"},{"issue":"6","key":"557_CR38","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0039-6060(97)90202-6","volume":"122","author":"R Udelsman","year":"1997","unstructured":"Udelsman R, Chen H, Loman K, Pitt HA, Saudek CD (1997) Implanted programmable insulin pumps: one hundred fifty-three patient years of surgical experience. Surgery 122(6):1005\u20131011","journal-title":"Surgery"},{"issue":"6","key":"557_CR39","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1177\/039139889501800605","volume":"18","author":"Pinget M JN","year":"1995","unstructured":"Point study II group, JN Pinget M, Ortega F, Wix D, Margetaux J, Feinbock C, Diglas J, Mendl H, Irsigler K, Scavini M, Petrella G, Torri M, Cristallo M, Pozza G, Luddeke HJ, Groth T, Renner R, Hepp KD JLS (1995) Multicentre trial of a programmable implantable insulin pump in type I diabetes. Int J Artif Organs 18(6):322\u2013325","journal-title":"Int J Artif Organs"},{"issue":"6","key":"557_CR40","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.2337\/dc09-1758","volume":"33","author":"SJ Logtenberg","year":"2010","unstructured":"Logtenberg SJ, Kleefstra N, Houweling ST, Groenier KH, Gans RO, Bilo HJ (2010) Health-related quality of life, treatment satisfaction, and costs associated with intraperitoneal versus subcutaneous insulin administration in type 1 diabetes. Diabetes Care 33(6):1169\u20131172. doi: 10.2337\/dc09-1758","journal-title":"Diabetes Care"},{"issue":"8","key":"557_CR41","doi-asserted-by":"crossref","first-page":"812","DOI":"10.2337\/diacare.19.8.812","volume":"19","author":"E Renard","year":"1996","unstructured":"Renard E, Bouteleau S, Jacques-Apostol D, Lauton D, Gibert-Boulet F, Costalat G, Bringer J, Jaffiol C (1996) Insulin underdelivery from implanted pumps using peritoneal route: determinant role of insulin pump compatibility. Diabetes Care 19(8):812\u2013817","journal-title":"Diabetes Care"},{"issue":"Suppl. 2","key":"557_CR42","doi-asserted-by":"crossref","first-page":"S169","DOI":"10.1016\/S0168-8227(06)70025-0","volume":"74","author":"CD Saudek","year":"2006","unstructured":"Saudek CD (2006) Implantable insulin pumps: the veterans administration study, a decade later. Diabetes Res Clin Pract 74(Suppl. 2):S169\u2013S172. doi: 10.1016\/S0168-8227%2806%2970025-0","journal-title":"Diabetes Res Clin Pract"},{"key":"557_CR43","unstructured":"European Medicines Agency-Committee for Medicinal Products for Human Use (CHMP) (2013) Summary of the European public assessment report (EPAR) for insuman including annex 1: summary of product characteristics. United Kingdom"},{"key":"557_CR44","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/S1096-6374(10)70067-8","volume":"20","author":"H Arnqvist","year":"2010","unstructured":"Arnqvist H, Frystyk J, Lindstrm T, Oscarsson P, Hedman CE (2010) Higher circulating IGF-I bioactivity and total IGF-I with intraperitoneal insulin delivery than with CSII in type 1 diabetes. Growth Horm IGF Res 20:S24\u2013S25. doi: 10.1016\/S109663741070067-8","journal-title":"Growth Horm IGF Res"},{"issue":"12","key":"557_CR45","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1007\/s001250050604","volume":"39","author":"H Hanaire-Broutin","year":"1996","unstructured":"Hanaire-Broutin H, Sallerin-Caute B, Poncet MF, Tauber M, Bastide R, Chale JJ, Rosenfeld R, Tauber JP (1996) Effect of intraperitoneal insulin delivery on growth hormone binding protein, insulin-like growth factor (IGF)-I, and IGF-binding protein-3 in IDDM. Diabetologia 39(12):1498\u20131504. doi: 10.1007\/s001250050604","journal-title":"Diabetologia"},{"issue":"6","key":"557_CR46","first-page":"420","volume":"22","author":"JD Bagdade","year":"1996","unstructured":"Bagdade JD, Dunn FL (1996) Improved lipoprotein surface and core lipid composition following intraperitoneal insulin delivery in insulin-dependent diabetes mellitus. Diabetes Metab 22(6):420\u2013426","journal-title":"Diabetes Metab"},{"issue":"2","key":"557_CR47","first-page":"133","volume":"28","author":"B Catargi","year":"2002","unstructured":"Catargi B, Meyer L, Melki V, Renard E, Jeandidier N (2002) Comparison of blood glucose stability and HbA1C between implantable insulin pumps using U400 HOE 21PH insulin and external pumps using lispro in type 1 diabetic patients: a pilot study. Diabetes Metab 28(2):133\u2013137","journal-title":"Diabetes Metab"},{"issue":"2","key":"557_CR48","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1210\/er.2009-0021","volume":"31","author":"SE Siegelaar","year":"2010","unstructured":"Siegelaar SE, Holleman F, Hoekstra JBL, DeVries JH (2010) Glucose variability; does it matter? Endocr Rev 31(2):171\u2013182. doi: 10.1210\/er.2009-0021","journal-title":"Endocr Rev"},{"issue":"3","key":"557_CR49","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00592-013-0459-9","volume":"50","author":"G Sartore","year":"2013","unstructured":"Sartore G, Chilelli N, Burlina S, Lapolla A (2013) Association between glucose variability as assessed by continuous glucose monitoring (CGM) and diabetic retinopathy in type 1 and type 2 diabetes. Acta Diabetol 50(3):437\u2013442. doi: 10.1007\/s00592-013-0459-9","journal-title":"Acta Diabetol"},{"key":"557_CR50","unstructured":"Review Manager (RevMan) [Computer program] (2011). 5.1. edn. The Nordic Cochrane Centre, The Cochrane collaboration, Copenhagen"},{"issue":"4","key":"557_CR51","first-page":"364","volume":"19","author":"E Renard","year":"1993","unstructured":"Renard E, Lauton D, Bonifacj C, Costalat G, Jacques D, Bringer J et al (1993) Experience with intraperitoneal insulin infusion from implantable programmable systems in type 1 (insulin-dependent) diabetes mellitus previously treated by external pumps. Diabete et Metabolisme 19(4):364\u2013371","journal-title":"Diabete et Metabolisme"},{"issue":"3","key":"557_CR52","doi-asserted-by":"crossref","first-page":"300","DOI":"10.2337\/diacare.18.3.300","volume":"18","author":"E Renard","year":"1995","unstructured":"Renard E, Baldet P, Picot MC, Jacques-Apostol D, Lauton D, Costalat G et al (1995) Catheter complications associated with implantable systems for peritoneal insulin delivery. An analysis of frequency, predisposing factors, and obstructing materials. Diabetes Care 18(3):300\u2013306","journal-title":"Diabetes Care"},{"issue":"3","key":"557_CR53","first-page":"940","volume":"24","author":"N Jeandidier","year":"1992","unstructured":"Jeandidier N, Pinget M, Keipes M, Louy S, Charton MN, Marescaux J et al (1992) Long-term treatment of type I diabetes in 28 patients using two different implantable programmable pumps. Transplant Proc 24(3):940\u2013941","journal-title":"Transplant Proc"},{"issue":"9","key":"557_CR54","first-page":"579","volume":"119","author":"J Marescaux","year":"1994","unstructured":"Marescaux J, Vix M, Mutter D, Jeandidier N, Boivin S, Pinget M (1994) A promising alternative for the treatment of type 1 diabetes mellitus. An implantable insulin pump. Une Alternative Seduisante Au Traitement Du Diabete De Type 1. La Pompe a Insuline Implantable [French]. Chirurgie\u2014Memoires de l'Academie de Chirurgie 119(9):579\u2013585","journal-title":"Chirurgie\u2014Memoires de l'Academie de Chirurgie"},{"key":"557_CR55","unstructured":"Keipes M, Michel G, Pinget M (1994) Implantable insulin pumps: evaluation after more than 3 years experience. Les Pompes a Insuline Implantables: Bilan Apres Plus De Trois Ans D'experience [French]. Bull Soc Sci Med Grand Duche Luxemb 131(1):17\u201330"},{"issue":"5","key":"557_CR56","first-page":"445","volume":"46","author":"Y Glock","year":"1992","unstructured":"Glock Y, Galinier P, Dalous P, Hanaire-Broutin H, Lacombe S, Lafon F et al (1992) Implantable insulin pump: Surgical implantation under local anesthesia (technical note based on thirty-five cases). La Pompe a Insuline Implantable: Implantation Chirurgicale Sous Anesthesie Locale (Note Technique a Propos De Trente-Cinq Cas) [French]. Ann Chir 46(5):445\u2013449","journal-title":"Ann Chir"},{"issue":"8896","key":"557_CR57","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0140-6736(94)91462-1","volume":"343","author":"C Broussolle","year":"1994","unstructured":"Broussolle C, Jeandidier N, Hanaire-Broutin H (1994) French multicentre experience of implantable insulin pumps. The EVADIAC Study Group. Evaluation of active implants in diabetes society. Lancet 343(8896):514\u2013515","journal-title":"Lancet"},{"issue":"6","key":"557_CR58","first-page":"399","volume":"90","author":"C Broussolle","year":"1994","unstructured":"Broussolle C, Gilly F, Sayag A, Ghouila T, Braillon G, Orgiazzi J (1994) Implantation of pumps to deliver intraperitoneal insulin in insulin-dependent diabetes: the experience from Lyon. Implantations De Pompes Pour Apport Intra-Peritoneal D'insuline Dans Le Diabete Insulinodependant: L'experience Lyonnaise [French]. Lyon Chirurgical 90(6):399\u2013402","journal-title":"Lyon Chirurgical"},{"issue":"6","key":"557_CR59","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0248-8663(05)80401-1","volume":"14","author":"D Raccah","year":"1993","unstructured":"Raccah D, Renard E, Ziegler O, Selam JL, Broussole C, Jeandidier N et al (1993) Multicentre evaluation of metabolic results of insulin implantable pump treatment. Experience of 269 patients x years. Evaluation Multicentrique Des Resultats Metaboliques Du Traitement Par Pompes a Insuline Implantables: Experience De 269 Patients X Annees [French]. Revue de Medecine Interne 14(6):455","journal-title":"Revue de Medecine Interne"},{"issue":"4","key":"557_CR60","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S0026-0495(96)90215-2","volume":"45","author":"B Guerci","year":"1996","unstructured":"Guerci B, Igau B, Ziegler O, Crea T, Fruchart JC, Drouin P et al (1996) Intraperitoneal insulin infusion improves the depletion in choline-containing phospholipids of lipoprotein B particles in type I diabetic patients. Metab 45(4):430\u2013434","journal-title":"Metab"},{"issue":"2","key":"557_CR61","first-page":"133","volume":"28","author":"B Catargi","year":"2002","unstructured":"Catargi B, Meyer L, Melki V, Renard E, Jeandidier N (2002) Comparison of blood glucose stability and HbA1C between implantable insulin pumps using U400 HOE 21PH insulin and external pumps using lispro in type 1 diabetic patients: a pilot study. Diabetes Metab 28(2):133\u2013137","journal-title":"Diabetes Metab"}],"container-title":["Acta Diabetologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-014-0557-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00592-014-0557-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-014-0557-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,16]],"date-time":"2020-08-16T00:09:52Z","timestamp":1597536592000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00592-014-0557-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,5]]},"references-count":61,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["557"],"URL":"https:\/\/doi.org\/10.1007\/s00592-014-0557-3","relation":{},"ISSN":["0940-5429","1432-5233"],"issn-type":[{"value":"0940-5429","type":"print"},{"value":"1432-5233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,5]]}}}